Your browser doesn't support javascript.
loading
Long-term use of tube feeding in children with cystic fibrosis: results from two Belgian CF centers.
Declercq, D; Huysentruyt, K; Hauser, B; De Wachter, E; Van Daele, S; De Baets, F; Van Biervliet, S.
Afiliação
  • Declercq D; Department of Pediatrics, Center for Cystic Fibrosis, Ghent University Hospital, Gent, Belgium. Dimitri.Declercq@ugent.be.
  • Huysentruyt K; Department of Paediatric Gastroenterology, Universitair ziekenhuis Brussel, Brussels, Belgium.
  • Hauser B; Department of Paediatric Gastroenterology, Universitair ziekenhuis Brussel, Brussels, Belgium.
  • De Wachter E; Department of Paediatric Pulmonology, Universitair ziekenhuis Brussel, Brussels, Belgium.
  • Van Daele S; Department of Pediatrics, Center for Cystic Fibrosis, Ghent University Hospital, Gent, Belgium.
  • De Baets F; Department of Pediatrics, Center for Cystic Fibrosis, Ghent University Hospital, Gent, Belgium.
  • Van Biervliet S; Department of Pediatrics, Center for Cystic Fibrosis, Ghent University Hospital, Gent, Belgium.
Eur J Clin Nutr ; 75(4): 620-627, 2021 04.
Article em En | MEDLINE | ID: mdl-33077878
ABSTRACT

BACKGROUND:

Enteral tube feeding (ETF) is often used in an attempt to optimize the nutritional status. The aim of this study was to observe the long term effect of ETF and to compare the start of ETF with the current European guidelines on nutrition care in CF.

METHOD:

From all patients who received ETF (ETFp) between February 2000 and September 2016 in the Ghent University Hospital (GUH) or Brussels University Hospital (BUH), z-scores for body weight (W), height (H), growth velocity (GV) and BMI, FEV1%, and FVC% were retrospectively collected from the patients' medical record, 3 years before and 5 years after the year of ETF initiation. Gender, age, and pancreatic status matched controls were selected from the GUH database.

RESULTS:

All baseline (T0) measurements in ETFp were worse compared to controls. Only 11% of the controls had a Hz < -1.6 compared 58% of the ETFp. After the initiation of ETF a rapid weight gain was noted until the second year (T + 2-1.9 (-2.8; -1.0) vs. T0-2.7 (-3.2; -2.1) (p = 0.01) with a stabilization afterwards. A rapid GVz increase was noted at T + 11.0 (-0.8; 1.9) vs. T0-1.5 (-2.0;-0.3). After the start of ETF until T + 3, a stabilization of FEV1% was noted. However, compared to controls, it remained significantly lower (p < 0.05).

CONCLUSION:

ETF as a nutritional intervention has its effect on weight, height, GV, and BMI. To our knowledge this is the first study that describes the evolution of growth in ETFp. The effect on GV argues for a faster introduction of ETF in malnourished children with CF.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nutrição Enteral / Fibrose Cística Tipo de estudo: Observational_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Eur J Clin Nutr Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nutrição Enteral / Fibrose Cística Tipo de estudo: Observational_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Eur J Clin Nutr Assunto da revista: CIENCIAS DA NUTRICAO Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica